Mutations in the MMP-2 gene lead to a number of disease processes, such as arthritis and metastasis, tumor growth vascular aneurysmal disease development, Winchester syndrome, and nodulosis-arthropathy-osteolysis (NAO) syndrome [47–50]. This evidence concerns the gene MMP2 and Nodulosis-arthropathy-osteolysis syndrome.